Mobile

A Multi-Centre, Open-Label, Single-Arm, and Multiple Dosing Trial on Safety of Monthly Replacement Therapy with Recombinant Factor XIII (rFXIII) in Subjects with Congenital Factor XIII Deficiency (S...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-007883-41

A Multi-Centre, Open-Label, Single-Arm, and Multiple Dosing Trial on Safety of Monthly Replacement Therapy with Recombinant Factor XIII (rFXIII) in Subjects with Congenital Factor XIII Deficiency (Safety Extension Trial to F13CD-1725)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the long term safety of monthly replacement therapy with rFXIII when used for prevention of bleeding episodes in subjects with congenital FXIII deficiency.

Critère d'inclusion

  • Congenital Factor XIII Deficiency

Liens